Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.
about
The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesisDevelopment of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesCoronavirus virulence genes with main focus on SARS-CoV envelope geneCoronavirus gene 7 counteracts host defenses and modulates virus virulenceGenome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replicationStructure and inhibition of the SARS coronavirus envelope protein ion channelStructure of a conserved Golgi complex-targeting signal in coronavirus envelope proteinsViral and Cellular mRNA Translation in Coronavirus-Infected Cells.Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesisImmunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus.The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis.The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.An immunosuppressed Syrian golden hamster model for SARS-CoV infection.Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.A Coronavirus E Protein Is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway.Coronavirus envelope (E) protein remains at the site of assemblySevere acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasomeCoronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids.Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine.Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope proteinComplete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge.Severe acute respiratory syndrome coronavirus protein 6 is required for optimal replication.Alphacoronavirus protein 7 modulates host innate immune response.Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidateSARS vaccines: where are we?Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survivalAnimal models in virus research: their utility and limitations.Self-Replicating RNA.Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong.A mouse model for MERS coronavirus-induced acute respiratory distress syndrome.Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through RecombinationAcquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirus.Molecular epidemiology and phylogenetic analysis of porcine epidemic diarrhea virus (PEDV) field isolates in Korea.Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice.Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.
P2860
Q24605877-4A5BD6FB-4029-4F35-B764-8044D96FFE44Q26782411-95B664C6-FC06-4B4A-9862-860E1E9C38F4Q26827561-9011C82F-60BB-4F7C-A738-9498ACC8485CQ27349527-A926C6D1-A078-42F2-9148-F94E7AADF3C0Q28473684-FAE60925-5ED9-4368-AA3F-1C39ADD5E31AQ28475712-84D02CD4-1D4E-4820-A398-C46B6021BA0CQ30360640-CA499B62-C8F4-46ED-B024-A5D00CECA099Q33553603-3B6623CF-AB9D-416A-AEF1-0139821A7329Q33553636-1AEF8FDC-AB8B-4463-AD81-6BC8FE11B2DAQ33695621-2B91D656-D81F-41F4-9200-EC2FFD3C81E6Q33921025-610CEF4B-F37F-4F24-B3B4-4D6E58703304Q34047499-08E2952D-C4C3-4505-B416-1B8294926505Q34057901-20ABCBF7-861C-4A96-8AFE-E53C9C20CCD5Q34058136-E7C2A1B1-8229-464C-ABC4-30D0D6CF4364Q34313436-681D7390-7AA8-43BD-BF81-21470794F21CQ34818143-AEC7F55A-9E9E-4872-BD4C-8D1BAA298033Q35487951-5E236068-57C5-4059-BFAB-AAF0A410DE5BQ35973638-09BEA01D-EB89-49EA-8E03-500E0CE083D2Q35998551-3B36D1B3-2F97-47A3-98D0-C5D9CC589932Q36202621-AC16D37A-7D05-489E-9E19-CFCE0C51CBF0Q36223700-C7C1F8EE-2C7D-47BE-A30C-15261A46C45FQ36224671-099F2856-514A-40F3-B80D-C0A94AF815C0Q36502511-39878F24-E401-431A-BF8B-CBAADCE6DDEDQ36911828-2A828138-1C3C-4DC9-8961-2AE81E59275EQ37025078-BDA62CF8-E685-477F-9418-347C647D9ADCQ37099656-72C57497-B23C-426A-BA85-3F415FB41AF0Q37123453-5A2FBFBC-7887-4637-97D4-656360BE74DDQ37174550-7F7FF2B1-579A-4E30-9753-514F47E226BFQ37524036-64B3FD2B-EB09-4C58-88C6-2D2F02D3682EQ37547432-65887937-2A38-461E-A63F-FA67505DCE15Q38043556-D58558D2-0E23-416B-A2C6-70683FD54578Q39093234-CD050DC4-4A30-43E6-8C3D-DB42742C9D3CQ40114934-E79ED0F0-1E9F-4230-8E09-5FD1F559E26BQ40433408-783A5AD8-4587-4F22-BA15-139BDD1F1934Q41055288-9B149975-5DF8-41EC-B268-B90F8D2F1703Q42181133-727FF7E6-D191-4CB2-A5C2-F00D008B3757Q42272420-83D7280C-FD8F-4D44-A9C1-17C33F4FC7F8Q44444682-1ABE1A69-1BFF-4BAD-9891-2AAE8508DDE0Q55056461-272BCB2E-0DDC-4142-8A3A-FFBE64F7C1EB
P2860
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@ast
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@en
type
label
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@ast
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@en
prefLabel
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@ast
Pathogenicity of severe acute ...... nts in hACE-2 transgenic mice.
@en
P2093
P2860
P50
P1433
P1476
Pathogenicity of severe acute ...... ants in hACE-2 transgenic mice
@en
P2093
Lecia Pewe
Maria Teresa Rejas
Marta L Dediego
P2860
P304
P356
10.1016/J.VIROL.2008.03.005
P407
P577
2008-05-02T00:00:00Z